Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease
ABSTRACT: Familial Alzheimer's disease (FAD) presenilin 1 E280A (PSEN1 E280A) is a severe neurological condition due to the loss of cholinergic neurons (ChNs), accumulation of amyloid beta (Aβ), and abnormal phosphorylation of the TAU protein. Up to date, there are no effective therapies availa...
- Autores:
-
Giraldo Berrío, Daniela
Jiménez del Río, Marlene
Vélez Pardo, Carlos Alberto
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2024
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/42374
- Acceso en línea:
- https://hdl.handle.net/10495/42374
- Palabra clave:
- Enfermedad de Alzheimer
Alzheimer Disease
Apoptosis
Caspasa 3
Caspase 3
Proteína Desglicasa DJ-1
Protein Deglycase DJ-1
Péptidos beta-Amiloides
Amyloid beta-Peptides
Peróxido de Hidrógeno
Hydrogen Peroxide
Minociclina
Minocycline
https://id.nlm.nih.gov/mesh/D001618
https://id.nlm.nih.gov/mesh/D017209
https://id.nlm.nih.gov/mesh/D053148
https://id.nlm.nih.gov/mesh/D000071617
https://id.nlm.nih.gov/mesh/D016229
https://id.nlm.nih.gov/mesh/D006861
https://id.nlm.nih.gov/mesh/D008911
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
| id |
UDEA2_5c9f2e943df204b078b88e1cf772b84d |
|---|---|
| oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/42374 |
| network_acronym_str |
UDEA2 |
| network_name_str |
Repositorio UdeA |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease |
| title |
Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease |
| spellingShingle |
Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease Enfermedad de Alzheimer Alzheimer Disease Apoptosis Caspasa 3 Caspase 3 Proteína Desglicasa DJ-1 Protein Deglycase DJ-1 Péptidos beta-Amiloides Amyloid beta-Peptides Peróxido de Hidrógeno Hydrogen Peroxide Minociclina Minocycline https://id.nlm.nih.gov/mesh/D001618 https://id.nlm.nih.gov/mesh/D017209 https://id.nlm.nih.gov/mesh/D053148 https://id.nlm.nih.gov/mesh/D000071617 https://id.nlm.nih.gov/mesh/D016229 https://id.nlm.nih.gov/mesh/D006861 https://id.nlm.nih.gov/mesh/D008911 |
| title_short |
Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease |
| title_full |
Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease |
| title_fullStr |
Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease |
| title_full_unstemmed |
Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease |
| title_sort |
Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s disease |
| dc.creator.fl_str_mv |
Giraldo Berrío, Daniela Jiménez del Río, Marlene Vélez Pardo, Carlos Alberto |
| dc.contributor.author.none.fl_str_mv |
Giraldo Berrío, Daniela Jiménez del Río, Marlene Vélez Pardo, Carlos Alberto |
| dc.contributor.researchgroup.spa.fl_str_mv |
Grupo de Neurociencias de Antioquia |
| dc.subject.decs.none.fl_str_mv |
Enfermedad de Alzheimer Alzheimer Disease Apoptosis Caspasa 3 Caspase 3 Proteína Desglicasa DJ-1 Protein Deglycase DJ-1 Péptidos beta-Amiloides Amyloid beta-Peptides Peróxido de Hidrógeno Hydrogen Peroxide Minociclina Minocycline |
| topic |
Enfermedad de Alzheimer Alzheimer Disease Apoptosis Caspasa 3 Caspase 3 Proteína Desglicasa DJ-1 Protein Deglycase DJ-1 Péptidos beta-Amiloides Amyloid beta-Peptides Peróxido de Hidrógeno Hydrogen Peroxide Minociclina Minocycline https://id.nlm.nih.gov/mesh/D001618 https://id.nlm.nih.gov/mesh/D017209 https://id.nlm.nih.gov/mesh/D053148 https://id.nlm.nih.gov/mesh/D000071617 https://id.nlm.nih.gov/mesh/D016229 https://id.nlm.nih.gov/mesh/D006861 https://id.nlm.nih.gov/mesh/D008911 |
| dc.subject.meshuri.none.fl_str_mv |
https://id.nlm.nih.gov/mesh/D001618 https://id.nlm.nih.gov/mesh/D017209 https://id.nlm.nih.gov/mesh/D053148 https://id.nlm.nih.gov/mesh/D000071617 https://id.nlm.nih.gov/mesh/D016229 https://id.nlm.nih.gov/mesh/D006861 https://id.nlm.nih.gov/mesh/D008911 |
| description |
ABSTRACT: Familial Alzheimer's disease (FAD) presenilin 1 E280A (PSEN1 E280A) is a severe neurological condition due to the loss of cholinergic neurons (ChNs), accumulation of amyloid beta (Aβ), and abnormal phosphorylation of the TAU protein. Up to date, there are no effective therapies available. The need for innovative treatments for this illness is critical. We found that minocycline (MC, 5 μM) was innocuous toward wild-type (WT) PSEN1 ChLNs but significantly (i) reduces the accumulation of intracellular Aβ by -69%, (ii) blocks both abnormal phosphorylation of the protein TAU at residue Ser202/Thr205 by -33% and (iii) phosphorylation of the proapoptotic transcription factor c-JUN at residue Ser63/Ser73 by -25%, (iv) diminishes oxidized DJ-1 at Cys106-SO3 by -29%, (v) downregulates the expression of transcription factor TP53, (vi) BH-3-only protein PUMA, and (vii) cleaved caspase 3 (CC3) by -33, -86, and -78%, respectively, compared with untreated PSEN1 E280A ChLNs. Additionally, MC increases the response to ACh-induced Ca2+ influx by +92% in mutant ChLNs. Oxygen radical absorbance capacity (ORAC) and ferric ion-reducing antioxidant power (FRAP) analysis showed that MC might operate more efficiently as a hydrogen atom transfer agent than a single electron transfer agent. In silico molecular docking analysis predicts that MC binds with high affinity to Aβ (Vina Score -6.6 kcal/mol), TAU (VS -6.5 kcal/mol), and caspase 3 (VS -7.1 kcal/mol). Taken together, our findings suggest that MC demonstrates antioxidant, anti-amyloid, and anti-apoptosis activity and promotes physiological ACh-induced Ca2+ influx in PSEN1 E280A ChLNs. The MC has therapeutic potential for treating early-onset FAD. |
| publishDate |
2024 |
| dc.date.accessioned.none.fl_str_mv |
2024-09-24T15:47:03Z |
| dc.date.available.none.fl_str_mv |
2024-09-24T15:47:03Z |
| dc.date.issued.none.fl_str_mv |
2024 |
| dc.type.spa.fl_str_mv |
Artículo de investigación |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ART |
| dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| status_str |
publishedVersion |
| dc.identifier.citation.spa.fl_str_mv |
Giraldo-Berrío D, Jiménez-Del-Río M, Vélez-Pardo C. Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer's disease. Neuropharmacology. 2024 Sep 7;261:110152. doi: 10.1016/j.neuropharm.2024.110152. |
| dc.identifier.issn.none.fl_str_mv |
0028-3908 |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/10495/42374 |
| dc.identifier.doi.none.fl_str_mv |
10.1016/j.neuropharm.2024.110152 |
| dc.identifier.eissn.none.fl_str_mv |
1873-7064 |
| identifier_str_mv |
Giraldo-Berrío D, Jiménez-Del-Río M, Vélez-Pardo C. Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer's disease. Neuropharmacology. 2024 Sep 7;261:110152. doi: 10.1016/j.neuropharm.2024.110152. 0028-3908 10.1016/j.neuropharm.2024.110152 1873-7064 |
| url |
https://hdl.handle.net/10495/42374 |
| dc.language.iso.spa.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
Neuropharmacology |
| dc.relation.citationendpage.spa.fl_str_mv |
16 |
| dc.relation.citationstartpage.spa.fl_str_mv |
1 |
| dc.relation.citationvolume.spa.fl_str_mv |
261 |
| dc.relation.ispartofjournal.spa.fl_str_mv |
Neuropharmacology |
| dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ https://creativecommons.org/licenses/by-nc-nd/4.0/ http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.extent.spa.fl_str_mv |
16 páginas |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Elsevier |
| dc.publisher.place.spa.fl_str_mv |
Oxford, Inglaterra |
| institution |
Universidad de Antioquia |
| bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstreams/d3801f06-6d7a-4c55-9a72-4742d71abc43/download https://bibliotecadigital.udea.edu.co/bitstreams/c463be06-4569-495b-823a-f875c6f5689d/download https://bibliotecadigital.udea.edu.co/bitstreams/f89184f9-0f52-4b43-b7c2-da2baa2c6eaf/download https://bibliotecadigital.udea.edu.co/bitstreams/1d1fe8b6-068c-43ff-bd68-fd9e02f7754b/download https://bibliotecadigital.udea.edu.co/bitstreams/23e6b076-a330-4313-bda9-9a82fab7d937/download |
| bitstream.checksum.fl_str_mv |
3305e939f37f877f3b8d919c6901c7ff b88b088d9957e670ce3b3fbe2eedbc13 8a4605be74aa9ea9d79846c1fba20a33 c871be45b68d1b9862af029b669e69d8 e651da129af7e5c2cbb9ff475c4e0ff1 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional de la Universidad de Antioquia |
| repository.mail.fl_str_mv |
aplicacionbibliotecadigitalbiblioteca@udea.edu.co |
| _version_ |
1851052214268723200 |
| spelling |
Giraldo Berrío, DanielaJiménez del Río, MarleneVélez Pardo, Carlos AlbertoGrupo de Neurociencias de Antioquia2024-09-24T15:47:03Z2024-09-24T15:47:03Z2024Giraldo-Berrío D, Jiménez-Del-Río M, Vélez-Pardo C. Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer's disease. Neuropharmacology. 2024 Sep 7;261:110152. doi: 10.1016/j.neuropharm.2024.110152.0028-3908https://hdl.handle.net/10495/4237410.1016/j.neuropharm.2024.1101521873-7064ABSTRACT: Familial Alzheimer's disease (FAD) presenilin 1 E280A (PSEN1 E280A) is a severe neurological condition due to the loss of cholinergic neurons (ChNs), accumulation of amyloid beta (Aβ), and abnormal phosphorylation of the TAU protein. Up to date, there are no effective therapies available. The need for innovative treatments for this illness is critical. We found that minocycline (MC, 5 μM) was innocuous toward wild-type (WT) PSEN1 ChLNs but significantly (i) reduces the accumulation of intracellular Aβ by -69%, (ii) blocks both abnormal phosphorylation of the protein TAU at residue Ser202/Thr205 by -33% and (iii) phosphorylation of the proapoptotic transcription factor c-JUN at residue Ser63/Ser73 by -25%, (iv) diminishes oxidized DJ-1 at Cys106-SO3 by -29%, (v) downregulates the expression of transcription factor TP53, (vi) BH-3-only protein PUMA, and (vii) cleaved caspase 3 (CC3) by -33, -86, and -78%, respectively, compared with untreated PSEN1 E280A ChLNs. Additionally, MC increases the response to ACh-induced Ca2+ influx by +92% in mutant ChLNs. Oxygen radical absorbance capacity (ORAC) and ferric ion-reducing antioxidant power (FRAP) analysis showed that MC might operate more efficiently as a hydrogen atom transfer agent than a single electron transfer agent. In silico molecular docking analysis predicts that MC binds with high affinity to Aβ (Vina Score -6.6 kcal/mol), TAU (VS -6.5 kcal/mol), and caspase 3 (VS -7.1 kcal/mol). Taken together, our findings suggest that MC demonstrates antioxidant, anti-amyloid, and anti-apoptosis activity and promotes physiological ACh-induced Ca2+ influx in PSEN1 E280A ChLNs. The MC has therapeutic potential for treating early-onset FAD.COL001074416 páginasapplication/pdfengElsevierOxford, Inglaterrahttp://creativecommons.org/licenses/by-nc-nd/2.5/co/https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Minocycline mitigates Aβ and TAU pathology, neuronal dysfunction, and death in the PSEN1 E280A cholinergic-like neurons model of familial Alzheimer’s diseaseArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionEnfermedad de AlzheimerAlzheimer DiseaseApoptosisCaspasa 3Caspase 3Proteína Desglicasa DJ-1Protein Deglycase DJ-1Péptidos beta-AmiloidesAmyloid beta-PeptidesPeróxido de HidrógenoHydrogen PeroxideMinociclinaMinocyclinehttps://id.nlm.nih.gov/mesh/D001618https://id.nlm.nih.gov/mesh/D017209https://id.nlm.nih.gov/mesh/D053148https://id.nlm.nih.gov/mesh/D000071617https://id.nlm.nih.gov/mesh/D016229https://id.nlm.nih.gov/mesh/D006861https://id.nlm.nih.gov/mesh/D008911Neuropharmacology161261NeuropharmacologyPublicationORIGINALGiraldoDaniela_2024_Minocycline_Mitigates_Aβ_TAU.pdfGiraldoDaniela_2024_Minocycline_Mitigates_Aβ_TAU.pdfArtículo de investigaciónapplication/pdf12991689https://bibliotecadigital.udea.edu.co/bitstreams/d3801f06-6d7a-4c55-9a72-4742d71abc43/download3305e939f37f877f3b8d919c6901c7ffMD51trueAnonymousREADCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstreams/c463be06-4569-495b-823a-f875c6f5689d/downloadb88b088d9957e670ce3b3fbe2eedbc13MD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/f89184f9-0f52-4b43-b7c2-da2baa2c6eaf/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADTEXTGiraldoDaniela_2024_Minocycline_Mitigates_Aβ_TAU.pdf.txtGiraldoDaniela_2024_Minocycline_Mitigates_Aβ_TAU.pdf.txtExtracted texttext/plain84504https://bibliotecadigital.udea.edu.co/bitstreams/1d1fe8b6-068c-43ff-bd68-fd9e02f7754b/downloadc871be45b68d1b9862af029b669e69d8MD54falseAnonymousREADTHUMBNAILGiraldoDaniela_2024_Minocycline_Mitigates_Aβ_TAU.pdf.jpgGiraldoDaniela_2024_Minocycline_Mitigates_Aβ_TAU.pdf.jpgGenerated Thumbnailimage/jpeg14651https://bibliotecadigital.udea.edu.co/bitstreams/23e6b076-a330-4313-bda9-9a82fab7d937/downloade651da129af7e5c2cbb9ff475c4e0ff1MD55falseAnonymousREAD10495/42374oai:bibliotecadigital.udea.edu.co:10495/423742025-03-26 18:43:28.227http://creativecommons.org/licenses/by-nc-nd/2.5/co/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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 |
